223 related articles for article (PubMed ID: 35255350)
1. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
2. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
[TBL] [Abstract][Full Text] [Related]
4. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
Cho H
Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
[TBL] [Abstract][Full Text] [Related]
6. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
Agrawal N; Dhakrey P; Pathak S
Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
[TBL] [Abstract][Full Text] [Related]
8. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
Zhang ZY; Lee SY
Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
Goldstein BJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
[TBL] [Abstract][Full Text] [Related]
10. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in PTP1B signaling in metabolism and cancer.
Villamar-Cruz O; Loza-Mejía MA; Arias-Romero LE; Camacho-Arroyo I
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34726241
[TBL] [Abstract][Full Text] [Related]
13. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
Popov D
Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
[TBL] [Abstract][Full Text] [Related]
14. [Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
Derkach KV; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Kuznetsova VS; Shpakov AO
Biomed Khim; 2022 Dec; 68(6):427-436. PubMed ID: 36573409
[TBL] [Abstract][Full Text] [Related]
15. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
Prabhakar PK; Sivakumar PM
Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.
Qian S; Zhang M; He Y; Wang W; Liu S
Future Med Chem; 2016 Jul; 8(11):1239-58. PubMed ID: 27357615
[TBL] [Abstract][Full Text] [Related]
17. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
[TBL] [Abstract][Full Text] [Related]
18. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in protein tyrosine phosphatase 1B inhibitors.
Taylor SD; Hill B
Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
[TBL] [Abstract][Full Text] [Related]
20. Small molecules as potent protein tyrosine phosphatase 1B (PTP1B) inhibitors documented in patents from 2009 to 2013.
Wang LJ; Jiang B; Wu N; Wang SY; Shi DY
Mini Rev Med Chem; 2015; 15(2):104-22. PubMed ID: 25643610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
